FDA Approves Bimekizumab for Plaque Psoriasis in Adults FDA Approves Bimekizumab for Plaque Psoriasis in Adults

Bimekizumab is the first IL-17A and IL-17F inhibitor approved by the FDA for adults with psoriasis.Medscape Medical News

Source: Medscape Dermatology Headlines - October 18, 2023 Category: Dermatology Tags: Dermatology News Alert Source Type: news